Considering health insurance: How do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage

Nephrology Dialysis Transplantation

Volumn 25, Issue 1, 2010, Pages 198-205

  Wetmore, James B ^a   Rigler, Sally K ^a   Mahnken, Jonathan D ^a   Mukhopadhyay, Purna ^a   Shireman, Theresa I ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Demographics; Dialysis; End stage renal disease; Insurance; Medicaid

Indexed keywords

HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EMPLOYMENT; FEMALE; GENDER; GLOMERULONEPHRITIS; HEART FAILURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HIGH RISK BEHAVIOR; HISPANIC; HUMAN; HYPERTENSION; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MINORITY GROUP; PERITONEAL DIALYSIS; PHYSICAL DISABILITY; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RACE; SELF CARE; SUBSTANCE ABUSE;

AGED; COMORBIDITY; FEMALE; HUMANS; INSURANCE, HEALTH; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEDICAID; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK-TAKING; UNITED STATES;

EID: 72949115483     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp396     Document Type: Article

References (34)

1. Baker DW, Sudano JJ, Albert JM et al. Lack of health insurance and decline in overall health in late middle age. N Engl J Med 2001; 345: 1106-1112
2. Wharam JF, Landon BE, Galbraith AA et al. Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. JAMA 2007; 297: 1093-1102
3. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007; 298: 61-69
4. McWilliams JM, Meara E, Zaslavsky AM et al. Health of previously uninsured adults after acquiring Medicare coverage. JAMA 2007; 298: 2886-2894
5. Ward MM. Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis. J Rheumatol 2007; 34: 2024-2027
6. Ward MM. Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care? Arch Intern Med 2007; 167: 1083-1091
7. Holley JL, DeVore CC. Why all prescribed medications are not taken: results from a survey of chronic dialysis patients. Adv Perit Dial 2006; 22: 162-166
8. Gill JS, Hussain S, Rose C et al. Access to kidney transplantation among patients insured by the United States Department of Veterans Affairs. J Am Soc Nephrol 2007; 18: 2592-2599
9. Lockridge RS, Jr. The direction of end-stage renal disease reimbursement in the United States. Semin Dial 2004; 17: 125-130
10. United States Renal Data System., USRDS 2006 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006
11. USRDS United States Renal Data System. 2004 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2004 In
12. Agresti A. Categorical Data Analysis. 2nd edn. New York: John Wiley & Sons, Inc., 1990
13. Rutledge MS, McLaughlin CG. Hispanics and health insurance coverage: the rising disparity. Med Care 2008; 46: 1086-1092
14. Benabe JE, Rios EV. Kidney disease in the Hispanic population: facing the growing challenge. J Natl Med Assoc 2004; 96: 789-798
15. Khawar O, Kalantar-Zadeh K, Lo WK et al. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol 2007; 2: 1317-1328
16. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555
17. Mehrotra R, Kermah D, Fried L et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 2007; 18: 2781-2788
18. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341: 427-434
19. Chalmers L, Kaskel FJ, Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv Chronic Kidney Dis 2006; 13: 352-364
20. Ching-Ha Kwan B, Beddhu S. Metabolic syndrome and chronic kidney disease. Minerva Urol Nefrol 2006; 58: 1-12
21. Eschbach JW, Kelly MR, Haley NR et al. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989; 321: 158-163
22. Regidor DL, Kopple JD, Kovesdy CP et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17: 1181-1191
23. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084
24. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
25. Iglehart JK. The American health care system-Medicaid. N Engl J Med 1999; 340: 403-408
26. Dubay L, Kenney G. Expanding public health insurance to parents: effects on children's coverage under Medicaid. Health Serv Res 2003; 38: 1283-1301
27. Lameire N, Peeters P, Vanholder R et al. Peritoneal dialysis in Europe: an analysis of its rise and fall. Blood Purif 2006; 24: 107-114
28. Oreopoulos DG, Coleman S, Doyle E. Reversing the decreasing peritoneal dialysis (PD) trend in Ontario: a government initiative to increase PD use in Ontario to 30% by 2010. Perit Dial Int 2007; 27: 489-495
29. Mendelssohn DC. PD and the future: the role of PD in the overall management of ESRD. Blood Purif 2003; 21: 24-28
30. Jindal K. Revitalizing peritoneal dialysis: the Ontario approach. Perit Dial Int 2007; 27: 526-528
31. Winkelmayer WC, Glynn RJ, Levin R et al. Late referral and modality choice in end-stage renal disease. Kidney Int 2001; 60: 1547-1554
32. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 2002; 13: 1279-1287
33. Horl WH, de Alvaro F, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14(Suppl 6): 10-15
34. Longenecker JC, Coresh J, Klag MJ et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000; 11: 520-529